Welcome to the inaugural edition of ‘Obesity Wire’, a dedicated newsletter designed to equip healthcare providers with the latest advancements, best practices, and transformative insights in the field of obesity and metabolic care. As providers on the front lines of healthcare, you play a crucial role in addressing the multifaceted…
Discovery of Obesity Gene Offers New Insights into Brain Activity Regulation A recent study published by Neuroscience News has identified…
Pfizer’s New Obesity Drug Danuglipron Shows Promise in Weight Loss Pfizer is making headlines with its new daily medication, Danuglipron,…
Beyond Blood Sugar: How Diabetes Drugs Like Ozempic Could Lower Cancer and Obesity Risks Recent research highlighted in Medical News…
Latest NewsNew Brain Targets for GLP1-based Obesity Drugs May Reduce Weight Without Nausea A recent study reported by News-Medical reveals…